SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-149130
Filing Date
2024-05-29
Accepted
2024-05-29 16:02:29
Documents
10
Effectiveness Date
2024-05-29

Document Format Files

Seq Description Document Type Size
1 S-8 d840673ds8.htm S-8 54705
2 EX-5.1 d840673dex51.htm EX-5.1 7994
3 EX-23.1 d840673dex231.htm EX-23.1 1984
4 EX-99.1 d840673dex991.htm EX-99.1 148000
5 EX-99.2 d840673dex992.htm EX-99.2 45477
6 EX-99.3 d840673dex993.htm EX-99.3 30812
7 EX-99.4 d840673dex994.htm EX-99.4 43228
8 EX-99.5 d840673dex995.htm EX-99.5 32064
9 EX-FILING FEES d840673dexfilingfees.htm EX-FILING FEES 14178
10 GRAPHIC g840673g0529013436221.jpg GRAPHIC 2522
  Complete submission text file 0001193125-24-149130.txt   383149
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279784 | Film No.: 24998242
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)